search

Active clinical trials for "Liver Diseases"

Results 1151-1160 of 1972

Study Evaluating Novel Biomarkers of AKI (Acute Kidney Injury) in Post-operative Patients

Acute Kidney InjuryArterial Hypertension5 more

To validate the use of [TIMP-2]●[IGFBP-7] to predict AKI in patients undergoing major intra abdominal surgery.

Terminated5 enrollment criteria

Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact...

Non Alcoholic Fatty Liver Disease

The aim of the current study is to evaluate the association of fatty liver severity and endothelial function in Non-Alcoholic Fatty Liver Disease (NAFLD) patients and to find the impact of statin treatment compared to usual care or life style modification on endothelial function, liver steatosis and fibrosis.

Withdrawn12 enrollment criteria

Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease...

Liver DiseaseShort Bowel Syndrome

The purpose of this study is to investigate the usefulness of oral fish oil(Lovaza)in normalizing liver function in patients who have parenteral nutrition associated liver disease. The investigators believe that patients who take oral fish oil will normalize liver function faster than those who do not

Withdrawn13 enrollment criteria

The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function...

NASH - Nonalcoholic Steatohepatitis

The HepQuant SHUNT test, which is provided as a HepQuant SHUNT Liver Diagnostic Kit, is a minimally-invasive test of liver function and physiology which has been designated by the FDA as an investigational drug/device combination product. Enrollment into one of the 3 Gilead Selonsertib clinical trials (GS-US-416-2124, GS-US-384-1943/1944) is required for enrollment into the HepQuant study

Terminated10 enrollment criteria

The Impact of an Epidural Anesthetic on the Consumption of Sevoflurane in Major Abdominal Surgery...

Bowel DiseaseLiver Diseases2 more

Major abdominal surgery - like non-laparoscopic bowel resection, liver, gastric, or pancreas surgery - is performed under general anesthesia. Pain control for after the surgery can be achieved purely with intravenous and oral pain medication or in combination with freezing of the nerves. Nerve freezing (nerve block) placed before surgery has the potential to substantially reduce the amount of inhaled anesthetic given to the patient during surgery. This can benefit the patient with being more awake and crisp more quickly after surgery. It can also reduce cost to the system. A further benefit which has received very little attention so far, is that reducing the amount of inhaled anesthetic given also lowers the environmental footprint created by the anesthetic. The investigators of the proposed study plan to quantify the amount of inhaled anesthetic used for each case and will compare how the consumption is affected by whether the epidural block is applied before or after surgery. Patients will have a nerve block catheter (epidural catheter) placed prior to the induction of general anesthetic by an experienced regional anesthesiologist. The epidural catheter will be bolused with a solution to which the anesthesiologist is blinded which will either be local anesthetic or dextrose (sham). The general anesthetic will be conducted according to a the protocol with the aim of maintaining a standard anesthetic depth monitored by patient state index (PSI). Measurements of the MAC-Value (minimum alveolar concentration) of inhaled anesthetic will be recorded every five minutes and will be noted down by a blinded observer. At the end of the case the anesthesiologist blinded to the solution will inject another solution (now a dextrose (sham) or local anesthetic before the patient is woken up.

Withdrawn12 enrollment criteria

Shear-wave Elastography Diffuse Liver Disease

Chronic HepaticChronic Liver Disease and Cirrhosis

The aim of this study is to correlate between quantitative results of shear wave elastography and CT picture in diffuse liver disease, including liver cirrhosis.

Not yet recruiting3 enrollment criteria

Assessment of Fatty Liver With Thermo-acoustic Device

NASHNAFLD5 more

The study will evaluate the accuracy of hepatic steatosis estimation by thermo-acoustic ultrasound with estimation by MRI-PDFF (Proton Density Fat Fraction) . It will also evaluate the sensitivity of this device in the diagnosis of fatty liver.

Not yet recruiting8 enrollment criteria

Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver...

Heart Failure With Preserved Ejection FractionNon Alcoholic Fatty Liver

The aim of our study to determine the demography, relation between patients with heart failure with preserved ejection fraction and those with nonalcoholic fatty liver disease in Sohag university hospital.

Not yet recruiting2 enrollment criteria

Screening for Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty Liver Disease Patients...

Pancreatic Exocrine Insufficiency

to investigate the frequency of PEI in MAFLD

Not yet recruiting4 enrollment criteria

Effect of Thyroid Disorders in Liver Diseases

Fatty Liver Disease

Aims of the Research To detect correlation between hyperthyroidism and non alcoholic fatty liver disease (NAFLD). To detect hepatic risk in subclinical and clinical hypothyroidism . To detect early liver disorders in thyroid disorders using fibroscan .

Not yet recruiting6 enrollment criteria
1...115116117...198

Need Help? Contact our team!


We'll reach out to this number within 24 hrs